|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash and Due from Banks | ||||||||||
| Interest-Bearing Deposits at Other Financial Institutions | ||||||||||
| Total Cash and Cash Equivalents | ||||||||||
| Investment Securities Available-for-Sale, at Fair Value (amortized cost $99,530 and $104,010 respectively) | ||||||||||
| Restricted Stock | ||||||||||
| Loans Receivable, Net of Unearned Income | ||||||||||
| Allowance for Credit Losses | ||||||||||
| Loans Receivable, Net | ||||||||||
| Bank Owned Life Insurance | ||||||||||
| Premises and Equipment, Net | ||||||||||
| Accrued Interest Receivable | ||||||||||
| Real Estate Owned | ||||||||||
| Deferred Tax Asset, Net | ||||||||||
| Other Assets | ||||||||||
| Total Assets | ||||||||||
| Liabilities and Stockholders' Equity | ||||||||||
| Liabilities | ||||||||||
| Deposits | ||||||||||
| Interest-Bearing | ||||||||||
| Noninterest-Bearing | ||||||||||
| Advances from Borrowers for Taxes, Insurance, and Repairs | ||||||||||
| Short-Term Federal Home Loan Bank Advances | ||||||||||
| Other Liabilities | ||||||||||
| Total Liabilities | ||||||||||
| Stockholders' Equity | ||||||||||
| Common Stock - $0.01 Par Value; 20,000,000 Shares Authorized: 5,235,658 and 5,349,039 Shares Issued and Outstanding at June 30, 2026 and December 31, 2025 | ||||||||||
| Additional Paid-In Capital | ||||||||||
| Unearned ESOP Stock | ||||||||||
| Retained Earnings | ||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||
| Total Stockholders' Equity | ||||||||||
| Total Liabilities and Stockholders' Equity |
Loading...
